JOSANA COLLINS: Open Payments
NPI 1821617556 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 40 payments from 18 companies in 2025. Trend: 2023 $894 · 2024 $998 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $155 |
| Galderma Laboratories, L.P. | 6 | $100 |
| GENZYME CORPORATION | 3 | $100 |
| LEO Pharma Inc. | 1 | $99 |
| ABBVIE INC. | 5 | $99 |
| Amgen Inc. | 3 | $70 |
| Janssen Biotech, Inc. | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Boston Scientific Corporation | 2 | $48 |
Products named: Winlevi, DUPIXENT, ANZUPGO, OTEZLA, NEMLUVIO, TREMFYA, SKYRIZI, COSENTYX.
Industry payments across TX — which companies pay providers there.
